Daptiv Pharmaceuticals and DNC Aesthetics Share Comprehensive Treatment Strategies
Busan hosts the 'DEEP Symposium,' with 56 attendees, including medical professionals and speakers. NaBot, Violet, and Real-O Injects Pine, Dous, and Diclassi CaHA applications are introduced. Clinical cases, live procedures, and panel discussions explore treatment plans and techniques for individual patients.
Daptiv Pharmaceuticals (069620) (represented by Park Sung-Soo and Lee Chang-Jae) and DNC Aesthetics (led by Yoo Hyun-Seung) have shared their comprehensive treatment strategies, covering skin improvement, facial contouring, and lifting. They presented methods for selecting and combining products based on patient skin conditions, facial shapes, and treatment goals, supported by clinical cases.
The companies announced the two-day 'DEEP Symposium' at Lotte Hotel Busan, from the 24th to the 25th. The event, themed 'From Skin to Shape: A Full-Face Combination Strategy,' gathered medical professionals and speakers who utilize the companies' medical aesthetic products.
DEEP Symposium: Exploring Aesthetic Medicine Innovations
The DEEP Symposium, an initiative by Daewoong and DNC Aesthetics Medical, brought together medical professionals to delve into the latest trends and clinical experiences in aesthetic medicine. This specialized educational program, titled the 'Daewoong·DNC Aesthetics Medical-AEsthetic Expert Program', focused on sharing expertise and insights to enhance patient outcomes.
During the symposium, attendees explored the practical applications of key products, including the botulinum toxin 'Nabota', the fat-dissolving injectable 'Violet', the ECM-based 'Rialle Inject Fine', the lifting thread 'Dous', and the calcium hydroxyapatite (CaHA)-based 'Diclassy CaHA'. Through a combination of lectures, panel discussions, and live demonstrations, participants gained a comprehensive understanding of product characteristics and their optimal use in achieving patient goals.
Day 1: Focus on Skin Improvement and Facial Contouring
The first day of the symposium centered on enhancing skin quality and defining facial features. Dr. Son Moo-hyun, the director of CheongdamFnB Clinic, presented a strategy for complex procedures utilizing Nabota, Violet, and Rialle Inject Fine. Dr. Yoon Hyun-seung from Mimi Sum Clinic's Gimhae branch shared his clinical experiences and the process of tailoring treatment plans to individual patient needs.
Market Visual: Exploring Aesthetic Medicine Innovations
Panel Discussion: Unlocking Product Combinations and Targeted Strategies
The panel discussion, featuring two renowned experts, delved into the intricacies of product combinations and tailored strategies for different anatomical areas. Medical professionals in attendance engaged in a thoughtful exchange, exploring product characteristics and their practical applications based on diverse case studies. The discussion also shed light on valuable clinical insights and best practices for aesthetic procedures.
Day 2 Highlights: Live Demonstrations and Expert Insights
The second day of the symposium featured an insightful lecture by Dr. Park Tae-hyung, the director of Gangnam Skinny Clinic, followed by a live demonstration by Dr. Kim Seo-hwan, the director of Petit 2.7 Clinic.
Dr. Park Tae-hyung provided an in-depth analysis of facial contour changes post-energy-based device (EBD) treatments and shared his approach to addressing patient demands for further enhancements. He presented case studies and shared his experience with various product combinations, including Dous, DiClassy CaHA, and RIALO Inject Fine.
Dr. Kim Seo-hwan took the stage for a live broadcast, showcasing his expertise in product application methods and treatment techniques. Attendees had the opportunity to witness, through video, the practical implementation of the strategies discussed during the lectures, providing a unique and immersive learning experience.
Industry Leaders Emphasize Importance of Patient-Centric Approach in Aesthetic Medicine
"Understanding the unique characteristics of each product and tailoring treatment methods to individual patients is crucial in complex procedures," said Jun-Soo Yoon, head of Na-Botox Business at Daewoong Pharmaceutical Co., Ltd. "Moving forward, we aim to provide medical professionals with valuable insights for product selection and treatment planning through a series of educational initiatives, including clinical case lectures, live procedures, and panel discussions."
Hyun-Seung Yoo, CEO of DNC Esthetics, added, "The key to successful complex procedures lies in determining the specific improvements required by each patient and selecting the appropriate products and treatments accordingly. We will continue to offer educational programs, leveraging the product portfolio of Daewoong Pharmaceutical and DNC Esthetics, to enable medical professionals to explore diverse approaches and share their clinical experiences."
The recent "Deep Symposium" hosted by Daewoong Pharmaceutical and DNC Esthetics brought industry experts together to discuss the latest advancements in aesthetic medicine. The event, which featured a panel discussion, aimed to enhance medical professionals' understanding of complex procedures and product selection.
![[ESMO 2026 Analysis] HLB's Rivoceranib Delivers 11.8-Month PFS in Rare Cancer; Prepares for U.S. Launch of Lifiting](https://media.markettimes.co.kr/54-400x300.webp)